Clinical Evaluation and Therapeutic Effects of Combination Treatment with Mecobalamin + Vitamin E in Recurrent Oral Ulcer



      Recurrent oral ulcer is one of the most prevalent inflammatory ulcerative disorders of the oral mucosa. Due to the indeterminant cause and unpredictable course of the disease, clinical treatment of patients with recurrent oral ulcer is focused on relieving the pain, shortening the course of the disease, and prolonging the intermission period. Numerous chemical and biologic agents have been characterized as beneficial in the treatment of patients with recurrent oral ulcer, but there is currently no definitive therapy available. This study aimed to investigate the clinical effects and tolerability of combined mecobalamin tablets and vitamin E capsules in the treatment of recurrent oral ulcer.


      A total of 58 patients with recurrent oral ulcer admitted to our hospital were allocated to receive mecobalamin tablets + vitamin E soft capsules (test group) or Fe complex enzyme gargle only (control group) (n = 29 per group). Changes in parameters such as pain level, as measured on a 10-point visual analog scale (VAS); ulcer status and number of ulcers; proinflammatory cytokine levels; and quality of life, as measured using SF-36, from before to after treatment were measured. Mean intermission time and mean ulcer healing time were calculated. Total effectiveness rate was also calculated. The occurrences of adverse reactions in the two groups were quantified.


      The total intermission time interval was significantly longer, the mean ulcer healing time was considerably shorter, the total number of ulcers was appreciably less, and the total effectiveness rate was significantly greater in the test group compared to the control group (all, P < 0.05). The VAS scores were significantly greater after treatment than before treatment in both the test and control groups (mecobalamin + vitamin E, 2.16 [1.09] vs 7.87 [0.51]; control, 3.72 [1.15] vs 7.94 [0.56]; both, P < 0.05). Interleukin (IL)-8, tumor necrosis factor α, and C-reactive protein levels were appreciably down-regulated in both groups when compared to before treatment. In addition, IL-2 concentration and SF-36 scores were much greater after treatment in the test group with respect to the control group. Levels of IL-8, TNF-α, and CRP were significantly lesser in the test group than in the control group (all, P < 0.05).


      The combination of mecobalamin tablets and vitamin E soft capsules was effective in the treatment of recurrent oral ulcer. This combination can be used as an adjunctive therapy, offering effective pain control and improving quality of life in patients with oral ulcers.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Therapeutics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Thakrar P.
        • Shahid I C.
        Oral ulceration: an overview of diagnosis and management.
        Prim Dent J. 2016; 5: 30-33
        • Rivera C.
        Essentials of recurrent aphthous stomatitis.
        Biomed Rep. 2019; 11: 47-50
        • Edgar N.R.
        • Saleh D.
        • Miller R.A.
        Recurrent aphthous stomatitis: a review.
        J Clin Aesthet Dermatol. 2017; 10: 26-36
        • Messadi D.V.
        • Younai F.
        Aphthous ulcers.
        Dermatol Ther. 2010; 23: 281-290
        • Saikaly S.K.
        • Saikaly T.S.
        • Saikaly L.E.
        Recurrent aphthous ulceration: a review of potential causes and novel treatments.
        J Dermatolog Treat. 2018; 29: 542-552
        • Altenburg A.
        • et al.
        The treatment of chronic recurrent oral aphthous ulcers.
        Deutsches Arzteblatt Int. 2014; 111: 665-673
        • Shao Y.
        • Ding B.
        The anti-inflammatory effect of zhibaidihuang decoction on recurrent oral ulcer with Sirt1 as the key regulatory target.
        J Evid Based Complementary Altern Med. 2021;
        • Siu A.
        • Landon K.
        • Ramos D.M.
        Differential diagnosis and management of oral ulcers.
        Semin Cutan Med Surg. 2015; 34: 171-177
        • Kozlak S.T.
        • Walsh S.J.
        • Lalla R.V.
        • et al.
        Reduced dietary intake of vitamin B12 and folate in patients with recurrent aphthous stomatitis.
        J. Oral Pathol. Med. 2010; 39: 420-423
        • Rasi A.
        • et al.
        Comparing the effect of injectable vitamin B with conventional oral treatment on aphthous stomatitis.
        J Skin Stem Cell. 2018; 5: e69052
        • Qureshi N.
        • Li P.
        • Gu Q.
        Probiotic therapy in Helicobacter pylori infection: a potential strategy against a serious pathogen?.
        Applied Microbiol Biotechnol. 2019; 103: 1573-1588
        • Lalla R.V.
        • et al.
        Multivitamin therapy for recurrent aphthous stomatitis: a randomized, double-masked, placebo-controlled trial.
        J Am Dent Assoc. 2012; 143 (1939): 370-376
        • Kuna L.
        • et al.
        Peptic ulcer disease: a brief review of conventional therapy and herbal treatment options.
        J Clin Med. 2019; 8: 179
        • Tarakji B.
        • et al.
        Guideline for the diagnosis and treatment of recurrent aphthous stomatitis for dental practitioners.
        J Int Oral Health. 2015; 7: 74-80
        • Hapa A.
        • et al.
        Does recurrent aphthous stomatitis affect quality of life? A prospective study with 128 patients evaluating different treatment modalities.
        J Dermatolog Treat. 2011; 22: 215-220
        • Al-Amad S.H.
        • Hasan H.
        Vitamin D and hematinic deficiencies in patients with recurrent aphthous stomatitis.
        Clin. Oral Investig. 2020; 24: 2427-2432
        • Taleb R.
        • et al.
        Role of vitamin B12 in treating recurrent aphthous stomatitis: a review.
        Int J Vitam Nutr Res. 2020; : 1-8
        • Han R.P.
        • et al.
        Effectiveness of vitamin B12 on recurrent aphthous stomatitis in long term care: a systematic review.
        JBI Libr Syst Rev. 2010; 8: 1-15
        • Traber M.G.
        • Stevens J.F.
        Vitamins C and E: beneficial effects from a mechanistic perspective.
        Free Radical Biol Med. 2011; 51: 1000-1013
        • Rizvi S.
        • et al.
        The role of vitamin E in human health and some diseases.
        Sultan Qaboos Univ Med J. 2014; 14: e157-e165
        • Combs G.F.
        • McClung J.P.
        Vitamin E.
        in: Combs G.F. McClung J.P. The Vitamins. Fifth Edition. Academic Press, 2017: 207-242
        • Atkinson J.
        • Manor D.
        • Parker R.
        in: Lennarz W.J. Lane M.D. Encyclopedia of Biological Chemistry. Second Edition. Academic Press, Waltham2013: 545-550
        • Lalla R.V.
        • et al.
        Multivitamin therapy for recurrent aphthous stomatitis: a randomized, double-masked, placebo-controlled trial.
        J Am Dent Assoc. 2012; 143: 370-376
        • Vomero N.D.
        • Colpo E.
        Nutritional care in peptic ulcer.
        Arquivos Brasileiros de Cirurgia Digestiva. 2014; 27: 298-302
        • Janusz G.
        • et al.
        Lignin degradation: microorganisms, enzymes involved, genomes analysis and evolution.
        FEMS Microbiol Rev. 2017; 41: 941-962
        • Light S.H.
        • et al.
        A flavin-based extracellular electron transfer mechanism in diverse Gram-positive bacteria.
        Nature. 2018; 562: 140-144
        • Mueller E.A.
        • Levin P.A.
        • Garsin D.A.
        Bacterial cell wall quality control during environmental stress. mBio. 2020; 11 (-20): e02456
        • Sarris J.
        • et al.
        Participant experiences from chronic administration of a multivitamin versus placebo on subjective health and wellbeing: a double-blind qualitative analysis of a randomised controlled trial.
        Nutr J. 2012; 11: 110
        • Ruan H-H.
        • et al.
        Frequencies of abnormal humoral and cellular immune component levels in peripheral blood of patients with recurrent aphthous ulceration.
        J. Dent. Sci. 2018; 13: 124-130
        • Ozyurt K.
        • et al.
        Serum Th1, Th2 and Th17 cytokine profiles and alpha‐enolase levels in recurrent aphthous stomatitis.
        J. Oral Pathol. Med. 2014; 43: 691-695
        • Shen C.
        • et al.
        Serum interleukin‐6, interleukin‐17A, and tumor necrosis factor‐alpha in patients with recurrent aphthous stomatitis.
        J. Oral Pathol. Med. 2021; 50: 418-423
        • Gupta P.
        • Ashok L.
        • Naik S.R.
        Assessment of serum interleukin-8 as a sensitive serological marker in monitoring the therapeutic effect of levamisole in recurrent aphthous ulcers: a randomized control study.
        Indian J Dent Res. 2014; 25: 284
        • Kartal D.S.P.
        • et al.
        Significance of serum interleukin‐8 levels in patients with Behcet’s disease: High levels may indicate vascular involvement.
        Int. J. Dermatol. 2009; 48: 259-264
        • Lei J.B.
        • Yang L.
        Effects of Yangyin Liyan decoction combined with Yulin powder on chronic pharyngitis with Yin deficiency and lung dryness and its effect on serum inflammatory factors.
        J Mod Integr Tradit Chinese Western Med. 2016; 25: 3041-3044
        • Wang J.H.
        • Wei Z.H.
        • Du Y.H.
        Study on the medical name and etiology and pathogenesis of oral ulcer.
        J Liaoning Univ Tradit Chinese Med. 2016; 18: 181-183
        • Miao M.
        • et al.
        Effect of Shuangjinlian mixture on oral ulcer model in rat.
        Saudi J Biol Sci. 2019; 26: 790-794
        • Kayabasi S.
        • Hizli O.
        • Cayir S.
        A novel predictor parameter for active recurrent aphthous stomatitis: C-reactive protein to albumin ratio.
        Cureus. 2019; 11: e5965